These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 19635959)
1. In vitro 24-hour time-kill studies of vancomycin and linezolid in combination versus methicillin-resistant Staphylococcus aureus. Singh SR; Bacon AE; Young DC; Couch KA Antimicrob Agents Chemother; 2009 Oct; 53(10):4495-7. PubMed ID: 19635959 [TBL] [Abstract][Full Text] [Related]
2. Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains. Clark C; Kosowska-Shick K; McGhee P; Dewasse B; Beachel L; Appelbaum PC Antimicrob Agents Chemother; 2009 Jul; 53(7):3118-21. PubMed ID: 19433566 [TBL] [Abstract][Full Text] [Related]
3. In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus. Saravolatz LD; Pawlak J; Johnson L; Bonilla H; Saravolatz LD; Fakih MG; Fugelli A; Olsen WM Antimicrob Agents Chemother; 2012 Aug; 56(8):4478-82. PubMed ID: 22585222 [TBL] [Abstract][Full Text] [Related]
4. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA). Kaleem F; Usman J; Khalid A; Hassan A; Omair M J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides. Ribes S; Pachón-Ibáñez ME; Domínguez MA; Fernández R; Tubau F; Ariza J; Gudiol F; Cabellos C Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1361-7. PubMed ID: 20680368 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769 [TBL] [Abstract][Full Text] [Related]
7. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus. Grohs P; Kitzis MD; Gutmann L Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229 [TBL] [Abstract][Full Text] [Related]
8. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA). Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575 [TBL] [Abstract][Full Text] [Related]
10. In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin. Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Ge Y; Biek D; Batard E; Potel G Antimicrob Agents Chemother; 2009 Dec; 53(12):5300-2. PubMed ID: 19752276 [TBL] [Abstract][Full Text] [Related]
11. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients. Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766 [TBL] [Abstract][Full Text] [Related]
12. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Rio-Marques L; Hartke A; Bizzini A Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140 [TBL] [Abstract][Full Text] [Related]
13. Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus. Leonard SN; Cheung CM; Rybak MJ Antimicrob Agents Chemother; 2008 Aug; 52(8):2974-6. PubMed ID: 18519721 [TBL] [Abstract][Full Text] [Related]
14. Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing. Credito K; Lin G; Appelbaum PC Antimicrob Agents Chemother; 2007 Apr; 51(4):1508-11. PubMed ID: 17261625 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test]. Pelitli TS; Cesur S; Kınıklı S; Irmak H; Demiröz AP; Karakoç E Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309 [TBL] [Abstract][Full Text] [Related]
16. Colonization of the tip of a thoracic catheter by Enterococcus faecalis resistant to vancomycin and linezolid. Cian F; Luzzati R; Deiana ML; Ferrantelli N; Tonin E; Lagatolla C; Dolzani L J Med Microbiol; 2009 Aug; 58(Pt 8):1118-1121. PubMed ID: 19528174 [TBL] [Abstract][Full Text] [Related]
17. Comparative activities of TR-700 (torezolid) against staphylococcal blood isolates collected in Spain. Betriu C; Morales G; Rodríguez-Avial I; Culebras E; Gómez M; López-Fabal F; Picazo JJ Antimicrob Agents Chemother; 2010 May; 54(5):2212-5. PubMed ID: 20176900 [TBL] [Abstract][Full Text] [Related]